Sunil Healthcare Ltd (BSE: 537253) is a New Delhi, Delhi-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹72 Cr, it ranks #3,556 by market cap among the 6,137 Indian listed companies on FinBizNet, and #74 of 86 in Medicinal Chemicals and Botanical Products. At ₹69.00 (as of 25 Oct 2026), the share price is 15.9% below its 52-week high of ₹82.00 and 11.3% above its 52-week low of ₹62.00. The share price is down 0.6% over one year and up 11.6% over three months.
| Current Price | ₹69.00 |
|---|---|
| Market Cap | ₹72 Cr |
| BSE Code | 537253 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 17.9 |
| Return on Equity | 5.86% |
| Return on Assets | 2.42% |
| 52-Week Range | ₹62.00 – ₹82.00 |
| 1-Year Price Change | -0.6% |
| 3-Month Price Change | +11.6% |
| Beta (1Y) | 0.19 |
| Headquarters | New Delhi, Delhi |
| Website | www.sunilhealthcare.com |
Sunil Healthcare Limited engages in the manufacture and sale of empty hard gelatin, hydroxypropyl methylcellulose (HPMC), and pullulan capsules shells in India and internationally. Its products include EHG, BSE/TSE free, pearl, liquid fill, preservative free, stick free, flavored, SLS free, natural color, non-AZO, gelatin, HPMC/vegetable, and pullulan capsules. The company also provides ayurvedic products, such as haldi, ginger, vasaka, trifala, guduchi, salaki, punarvana, shatavari, hadjod, hingwastak, mulethi, arjuna, ashwagandha, and guggul extracts. The company offers its products under the SUNLOC brand name. Sunil Healthcare Limited was incorporated in 1973 and is based in New Delhi, India.
1. Sale of Capsule-This segment manufactures and sells empty hard gelatin and HPMC capsule shells. 2. Marketing of Food Products - Discontinued Operations-This segment markets food products. 3. Unallocated Assets-0 4. Segment Adjustment-0
1. Sale of Capsule-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4,21,995 Cr | 36.4 | 14.72% | ₹15,300 Cr | +5.4% |
| Zydus Lifesciences Ltd | ₹1,12,020 Cr | 22.2 | 18.32% | ₹8,017 Cr | +14.7% |
| Laurus Labs Ltd | ₹1,11,310 Cr | 125.3 | 17.74% | ₹2,026 Cr | +125.7% |
| Cipla Limited | ₹1,07,048 Cr | 27.6 | 11.74% | ₹7,119 Cr | -14.7% |
| Dr.Reddys Lab | ₹1,02,611 Cr | 24.1 | 11.52% | ₹8,698 Cr | -0.9% |
| Aurobindo Pharma Ltd. | ₹95,910 Cr | 26.8 | 9.93% | ₹9,150 Cr | +41.7% |
| Mankind Pharma | ₹93,977 Cr | 48.7 | 12.45% | ₹4,031 Cr | -9.9% |
| Lupin Ltd | ₹89,426 Cr | 16.6 | 26.91% | ₹8,277 Cr | -1.1% |
| Sunil Healthcare Ltd | ₹72 Cr | 17.9 | 5.86% | — | -0.6% |
Listed by market capitalisation. Ratios are shown for context only.
Sunil Healthcare Ltd is trading at ₹69.00, with a market capitalisation of ₹72 Cr.
Sunil Healthcare Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).
Sunil Healthcare Ltd has a P/E of 17.9 and a return on equity of 5.86%.
Sunil Healthcare Ltd is listed on the BSE under the scrip code 537253.
Sunil Healthcare Ltd's share price is down 0.6% over one year and up 11.6% over three months. Its 52-week range is ₹62.00 to ₹82.00.
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.